Stock IMCC IM CANNABIS CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings IM Cannabis Corp.

Equities

IMCC

CA44969Q3070

Delayed Canadian Securities Exchange
Other stock markets
 10:07:34 2024-06-05 am EDT 		5-day change 1st Jan Change
0.71 CAD -1.39% Intraday chart for IM Cannabis Corp. -13.41% +54.35%
May. 29 IM Cannabis Corp. announced that it has received CAD 2.091977 million in funding CI
May. 26 IM Cannabis Corp. announced that it expects to receive CAD 2.091977 million in funding CI

Strengths

  • Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach -98% by 2026.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

Weaknesses

  • As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
  • Low profitability weakens the company.
  • For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
  • The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
  • The company's earnings releases usually do not meet expectations.

Ratings chart - Surperformance

Sector: Pharmaceuticals

1st Jan change Capi. Investor Rating ESG Refinitiv
IM CANNABIS CORP. Stock IM Cannabis Corp.
+54.35% 7.05M - -
CURALEAF HOLDINGS, INC. Stock Curaleaf Holdings, Inc.
+11.07% 3.36B
C-
TRULIEVE CANNABIS CORP. Stock Trulieve Cannabis Corp.
+84.38% 1.72B
C
GOODNESS GROWTH HOLDINGS, INC. Stock Goodness Growth Holdings, Inc.
+166.67% 88.4M - -
Investor Rating
-
Trading Rating
-
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances
-

Valuation

P/E ratio
-
EV / Sales
-
Price to Book
-
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
-
4 months EPS revision
-

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
  1. Stock Market
  2. Equities
  3. IMCC Stock
  4. Ratings IM Cannabis Corp.